How a corporate feud doomed human trials of promising therapy.
D020811:Biomedical Technology; D001853:Bone Marrow; D004467:Economics; D035082:Federal Government; D005380:Financing, Government; D006076:Government; D006805:Human Experimentation; D006801:Humans; D007221:Industry; D007603:Jurisprudence; D007938:Leukemia; D008722:Methods; D009316:National Institutes of Health (U.S.); D009369:Neoplasms; D010330:Patents as Topic; D012106:Research; D019452:Terminally Ill; D036302:Therapeutic Human Experimentation; D016378:Tissue Transplantation; D014481:United States
Baxter International Inc.; Biomedical and Behavioral Research; Cell Pro Inc.; Health Care and Public Health; National Institutes of Health; Popular Approach/Source